Phase Forward Inc.

With an understanding of the clinical process and team members possessing experience in building complex trading systems for Wall Street, Phase Forward Inc. replaces the paper-laden clinical data management system with a computerized system that offers real-time electronic access to and management of clinical trial data.

Currently, clinical trial data is recorded, transmitted and managed by a time- and labor-intensive paper system. Data from trials often remains hidden for weeks in unprocessed piles of paper forms, and on average, an extra 12 to 15 weeks is required for data compilation and review before analysis can begin. This delay impedes the availability of new medical treatments and the potential to generate company revenues.

With an understanding of the clinical process and team members possessing experience in building complex trading systems for Wall Street,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from In Vivo

Podcast: Acuitas CSO On CRISPR Delivery Breakthrough And Next-Gen Lipid Nanoparticle Technology

 
• By 

In Vivo sits down with Ying Tam, CSO at Acuitas Therapeutics, to discuss the company's role in delivering the first personalized CRISPR treatment to an infant and the clinical implications of new lipid nanoparticle technologies.

BioBytes: AI-Related Deals In Q2 ‘25

 
• By 

When it came to AI-related deals, the second quarter of 2025 was characterized by mostly modest financings.

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 

The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.